Unichem Laboratories Ltd

UNICHEMLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,576 cr, stock is ranked 815
Moderate RiskStock is 2.57x as volatile as Nifty
253.4029.45 (+13.15%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,576 cr, stock is ranked 815
Moderate RiskStock is 2.57x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
45.93
PB RatioPB Ratio
0.62
Dividend YieldDiv. Yield
1.79%
Sector PESector PE
38.42
Sector PBSector PB
5.12
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020213.551.281.201.292.54-0.02-0.060.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnDec 2, 2021

Unichem Laboratories Limited has informed the Exchange regarding 'ANDA approval for Aripiprazole Tablets '. | Download

Unichem Laboratories Limited has informed the Exchange regarding 'ANDA approval for Aripiprazole Tablets '. | Download

Credit Rating 
Announced OnNov 26, 2021

Unichem Laboratories Limited has informed the Exchange about Credit Rating | Download

Unichem Laboratories Limited has informed the Exchange about Credit Rating | Download

Cash Dividend 
Ex. DateJul 22, 2021

Final • Div/Share: ₹ 4

See all events